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Transgenic Huntington rat, R6/2 miceDespite extensive research, the regulation of mitochondrial function is still not understood completely.
Ample evidence shows that cytosolic Ca2+ has a strategic task in co-ordinating the cellular work load and the
regeneration of ATP by mitochondria. Currently, the paradigmatic view is that Cacyt2+ taken up by the Ca2+
uniporter activates the matrix enzymes pyruvate dehydrogenase, α-ketoglutarate dehydrogenase and
isocitrate dehydrogenase. However, we have recently found that Ca2+ regulates the glutamate-dependent
state 3 respiration by the supply of glutamate to mitochondria via aralar, a mitochondrial glutamate/
aspartate carrier. Since this activation is not affected by ruthenium red, glutamate transport into
mitochondria is controlled exclusively by extramitochondrial Ca2+. Therefore, this discovery shows that
besides intramitochondrial also extramitochondrial Ca2+ regulates oxidative phosphorylation. This new
mechanism acts as a mitochondrial “gas pedal”, supplying the OXPHOS with substrate on demand. These
results are in line with recent ﬁndings of Satrustegui and Palmieri showing that aralar as part of the malate–
aspartate shuttle is involved in the Ca2+-dependent transport of reducing hydrogen equivalents (from
NADH) into mitochondria. This review summarises results and evidence as well as hypothetical
interpretations of data supporting the view that at the surface of mitochondria different regulatory Ca2+-
binding sites exist and can contribute to cellular energy homeostasis. Moreover, on the basis of our own data,
we propose that these surface Ca2+-binding sites may act as targets for neurotoxic proteins such as mutated
huntingtin and others. The binding of these proteins to Ca2+-binding sites can impair the regulation by Ca2+,
causing energetic depression and neurodegeneration.xyacetate; CAG, DNA code for
ase; CsA, cyclosporin A; DHAP,
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Oxidative phosphorylation is the main process responsible for ATP
production and NADH reoxidation. The central mechanism for
oxidative ATP synthesis has been known since Mitchell published his
chemiosmotic theory [1]. The demand for ATP varies with changes incellular functions, such as protein biosynthesis, ion transport,
secretion, proliferation, differentiation, and contractile work. At
present, the mechanisms controlling the balance between production
and utilisation of ATP are still poorly understood. Chance andWilliams
assumed on the basis of experiments with isolated mitochondria that
ADP formed by ATP-consuming enzymes represents a feedback signal,
which regulates OXPHOS and the rate of ATP synthesis [2,3].
This view has been supported by the inverse correlation of
mitochondrial activity with cytosolic phosphorylation potential
observed in experiments with mitochondria isolated from several
sources [4] and predicted by computer simulations that consider the
increased ADP and Pi levels to be direct activators of OXPHOS [5].
However, the results of in vivo studies based on 31P-NMR
spectroscopy do not ﬁt into the concept of regulation of OXPHOS
simply by cytosolic ﬂuctuations in ADP and Pi [6,7,9,10]. These studies
have shown that, whereas in contracting white skeletal muscle the
phosphorylation potential decreases with increasing work load [7–9],
the cardiac muscle is characterised by metabolic stability, as cytosolic
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beatingheart during periods of elevatedwork load [6,10]. It is clear from
these data that themechanisms of regulation of OXPHOS vary according
to the type of tissue. In contrast to glycolytic muscle, where OXPHOS is
controlled by cytosolic alterations in ADP and Pi [7–9], these mechan-
isms obviously do not exist in cardiac muscle [6,8,10]. To explain the
metabolic stability in cardiac muscle, two hypotheses have been
proposed. (i) Energy transfer by creatine kinase (CK)- and adenylate
kinase (AK)-mediated pathways, with direct channelling of adenine
nucleotides [11–19], and (ii) the parallel regulation by Ca2+ of OXPHOS
and cellwork [6,9,10]. Since energy transfer byCKandAK is reviewedby
Saks et al. in this issue, we will focus our review on regulation by Ca2+.2. OXPHOS regulation by intramitochondrial Ca2+
2.1. Regulation of mitochondrial dehydrogenases by Ca2+
To explain the stimulation of respiration in the absence of cytosolic
ADP ﬂuctuations, a hypothesis of parallel activation of OXPHOS and
ATPases has been put forward [6,9,20–26]. This hypothesis is based
upon theﬁndings that not only the extramitochondrial ATPases, but also
the mitochondrial dehydrogenases – such as the pyruvate dehydroge-
nase complex (PDHC), the NADH-isocitrate dehydrogenase (ICDH) andFig. 1. Accepted andpostulatedmitochondrial targets for regulationby extra- and intramitochond
dehydrogenase (α-KGDH), isocitrate dehydrogenase (ICDH) and the pyruvate dehydrogenase
via the Ca2+ uniporter [28–35], which has a Ca2+-binding site at the IMS site [30–33]. Ca2+ a
F0F1ATPase [127,131], or by post-translationalmodiﬁcations of the enzyme complexwithout
be activated by Ca2+-dependent dephosphorylation occurring in vitro at very high Ca2+ conce
of the PTP, where Ca2+ supports the closed state of the PTP [141,142]. Increasing intramitocho
ﬁndings support the possibility that the porin pores have a regulatory Ca2+-binding site that
Ca2+-binding motifs that are localised in the IMS and there sense the cytosolic Ca2+ concentr
nucleotides in a Ca2+-dependent manner [68,82,84–89]. FAD-GPDH oxidises GP to DHAP
mitochondrial Ca2+-dependent enzymes, Ca2+ activation of aralar occurs by increasing Vmax
cycle into themitochondria and, as part of themalate–aspartate shuttle, it also transports redo
[69,77,78] and therefore it is a preferred route.theα-ketoglutarate dehydrogenase (α-KGDH) [25,26] (Fig. 1, Table 1) –
can be activated by increased Ca2+ concentrations [21–26].
The activity of the PDHC is regulated by increasing the acetylCoA/
CoA and NADH/NAD+ ratios, and, more importantly, by reversible
phosphorylation of three sites of the E1 subunit by highly speciﬁc
kinases and phosphatases found in mitochondria [22,24]. PDHC is
phosphorylated and thereby inactivated by PDH kinase, whereas PDH
phosphatase (PDP) activates the enzyme [22,24]. The activation of
PDHC by Ca2+ is realised by the direct effect of that ion upon PDP
(S0.5=0.77) [22,27]. The activity of PDHC is independent of changes
in ATP/ADP ratios [21,22,24].
In coupled respiring heart mitochondria, extramitochondrial Ca2+
stimulated the α-KG oxidation up to fourfold at low concentrations
(0.2 mM) of α-KG, but at saturation concentrations (25 mM) no
stimulation occurs [25]. This was explained by the ﬁnding that Ca2+
reduces the KM for α-KG from 2.1 µM to 0.2 µM but does not change
the Vmax [23,25]. S0.5 for this activation is 0.4 µM Ca2+ in the presence
of ADP and 0.8 µM Ca2+ in the presence of ATP, indicating that the
sensitivity of α-KGDH to Ca2+ decreases as the ATP/ADP ratio
diminishes [24]. At the same time, there is no effect of Ca2+ on the KM
for the second substrate NAD+ [23,25].
Compared with α-KGDH and PDHC, much higher Ca2+ concentra-
tions are required to activate ICDH. As is the case for α-KGDH, the
sensitivity of ICDH increases with decreasing ATP/ADP ratiosrial Ca2+. There is ample evidence todemonstrate that thematrix enzymesα-ketoglutarate
complex (PDHC) are activated by risingmatrix Ca2+ [21–28]. Ca2+ accumulation occurs
ctivation of F0F1ATPase [20,127–144] is assumed via a release of inhibitor proteins from
the necessity of special Ca2+ binding sites [20,125]. Subunit I of cytochrome c oxidase can
ntrations [137,138]. A regulatory Ca2+-binding sitewas assumed to exist on the IMS side
ndrial Ca2+ induces the opening of PTP by activation of cyclophilin D [129–143]. Recent
can increase the permeability of porin [120–122]. The following enzymes have EF-hand
ation [68]. The MgATP/Pi carrier can increase or decrease the matrix content of adenine
and supplies the redox equivalents to coenzyme Q [91–99]. In contrast to the other
and not by decreasing KM. Aralar transports a real substrate (glutamate) for the citrate
x equivalents into themitochondria [68].Moreover, this substrate supply is electrogenic
Table 1






PDHC-phosphatase Inhibits 0.77(ADP) Activation of PDHC [22]
0.74 (ATP) Activation of PDHC [22]
α-KGDH Inhibits 0.28 (ADP) Decrease KM α-KG [22,26]
0.81 (ATP) Decrease KM α-KG [22,26]
ICDH Inhibits 5.4 (ADP) Decrease KM IC [22,26]
41 (ATP) Decrease KM IC [22,26]
Uniporter Inhibits Increases Ca2+ uptake [30–33]
KMN3 µM Ca2+ [31,33]
Spermine decreases KM [34,35]





FAD-GPDH No effect 0.3 Decrease of KM [93,95,98]
ATP-Mg/Pi carrier No effect 1–4 Decrease of KM [68,82]
PTP Shift to closed PTP [141,142]
Porin µM range Increasing permeability [120,121]




ATPase n.d. Increasing activity [123–136]
COX N100 Increasing activity [137,138]
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[22,24,26] and Ca2+ activation is realised through decreasing KM for
the substrates without changes in Vmax [22,24,26].
For all three dehydrogenases described it has been shown that their
activation by Ca2+ is abolished by ruthenium red (RR), an inhibitor of
the Ca2+uniporter. Therefore, itwas concluded that activation of these
dehydrogenases by Ca2+ occurs exclusively inside thematrix and thus
requires transport of Ca2+ into that compartment [21–26].
2.2. Mitochondrial Ca2+ accumulation via the Ca2+ uniporter
Mitochondria accumulate Cacyt2+ via the Ca2+ uniporter, which
facilitates the transport of Ca2+ down its electrochemical gradient
[28–31]. The uniporter can also transport other cations, but these can
act as competitive inhibitors of Ca2+ accumulation [28]. Kinetic
investigation of the accumulation of Ca2+ gave sigmoidal plots of
transport rate versus [Ca2+] and showed that the mechanism was of
second order with respect to [Ca2+], causing a Ca2+-induced
reinforcement of mitochondrial Ca2+ uptake [29–31]. These results
led to the conclusion that the uniporter has both a transport site and
an activation site, with different binding afﬁnities [30]. The activation
site may interact with nucleotides and divalent cations because both
nucleotides and Mg2+ can inhibit the uniporter activity [32]. It is also
assumed that the Ca2+ induced facilitation of Ca2+ uptake could be
mediated through effects of calmodulin on the uniporter [33,37].
The Vmax of the uniporter is clearly dependent on the membrane
potential [28]. However, its afﬁnity to Ca2+ is low, as K0.5 ranges from
1 to 189 µM [31,33]. Nevertheless, at lower Ca2+ concentrations
polyamines – such as spermine – increase signiﬁcantly the rate of Ca2+
inﬂux through the uniporter [34,35]. The amount of polyamines varies
somewhat between the cell types, being approximately 1 mM in the
cytoplasm of hepatocytes and about 0.3 mM in the cytosol of cardiac
myocytes; both of these concentrations are sufﬁcient to activate the
uniporter [36].
The Ca2+ uniporter plays an important role in connecting cytosolic
and intramitochondrial signalling by Ca2+ ions. Inmost cells, the resting
free Ca2+ concentration is in the range of 100–200 nM in the cytosol
[28,38–40]. With physiological stimulation, however, free Ca2+ in both
cytosol and mitochondria can increase rapidly and transiently by a
factor of 10–20, as occurs on a beat-to-beat basis in cardiac myocytes
owing to mitochondrial Ca2+ uptake [38]. It has been shown that Camit2+
responds promptly to changes in Cacyt2+, exactly following the Cacyt2+oscillations, thus providing a frequency-mediated signal which is
speciﬁcally decoded by the mitochondria as shown for hepatocytes
[39], cardiomyocytes [38] and HeLa cells [41].
Nicholls has shown in extensive studies [42–44] that brain
mitochondria start to accumulate Ca2+ if the concentration rises
above 0.5 µM [42,44]. Similar properties have been found for
mitochondria in situ within cultured neurons [45–47]. After accumu-
lation of more than 10 nmol Ca2+/mg the parallel accumulation of
phosphate causes formation of calcium phosphate in isolated
mitochondria [44] but also in situ in neurons [45], with a variable
calcium-to-phosphate ratio depending on the conditions [48]. This
calcium phosphate formation makes it possible that brain mitochon-
driamay act as a “perfect calciumbuffer”, effectively lowering the Cacyt2+
back to the 0.5 µM. If the cytosolic Ca2+ falls below that value the
mitochondria release Camit2+ again by dissolving the calcium phosphate
[42]. This means that brain mitochondria act as temporary reservoirs
of Ca2+, by taking up Ca2+ throughout the stimulation but releasing
this ion back into the cytoplasm when the plasma membrane and SR
ATPases pump down the Cacyt2+ [42]. As a result, the Ca2+ transients in
the neurons become smoother and more prolonged [42]. In quiescent
neurons, where Cacyt2+ is close to 0.1 µM, the mitochondrial matrix
is largely depleted of Ca2+ and Camit2+ varies as a function of Cacyt2+
[42]. Nicholls concluded from these results that the brain mitochon-
drial Ca2+ uptake fulﬁls two purposes: the activation of mitochondrial
dehydrogenases (if Camit2+ is lower than 10 nmol/mg) and the storage of
excess Ca2+ (in the range of 10–130 nmol/mg Ca2+) [42].
2.3. Problems with exclusive regulation of OXPHOS by
intramitochondrial Ca2+
As noted above, the observation that RR hinders the activation of
respiration by the effective inhibition of the Ca2+ uniporter has been
used as a main argument for the intramitochondrial Ca2+ stimulation
of mitochondrial dehydrogenases [22,23,49–51]. In some studies with
isolated heart mitochondria, only after addition of excessive high
(8 µM) RR a reduction in stimulation by Ca2+ was observed [51].
Results obtained with such large RR additions must be regarded with
caution, because in our hands high RR concentrations caused
unspeciﬁc inhibitions of mitochondrial functions [Gellerich et al.,
unpublished]. Although RR carries a strong positive charge, it can
enter a number of cell types. Therefore, it has been used to study the
effects of intramitochondrial Ca2+ on energy metabolism in perfused
tissues and cells [50–54]. To overcome the diffusion barrier of cellular
membranes in such experiments, higher RR concentrations were used
than applied with isolated mitochondria. With this approach it was
shown that the activation of PDHC (detected on a basis of altered
content of dephosphorylated PDHC in the tissue homogenate) was
completely blocked during the perfusion of heart muscle with a
medium containing RR; this was taken to indicate complete inhibition
of the Ca2+-uniporter [51–54]. However, in these studies the
surprising ﬁnding was that the work output actually was even
increased [52,53,55] despite of the RR inhibition. As expected the
decreasing ATP/ADP ratios indicated an impairment of metabolic
stability [52,53]. However, the observed small changes did not ﬁt with
the assumption that mitochondrial activity is regulated by changes of
intramitochondrial Ca2+. Another set of studies performed on MH75
cells has shown that changes in mitochondrial NADH do not correlate
with alterations in intramitochondrial Ca2+ [55]. In stimulated motor
nerve terminals Cacyt2+ – but not Camit2+ – correlates with the work load
adjusted by repetitive stimulations of different frequency and
intensity [56–58]. After cessation of stimulations the decrease of Camit2+
is much slower than that of Cacyt2+ [56–59]. Also, when the stimulation of
PDH, ICDH and α-KGDH by intramitochondrial Ca2+ was considered in
a computer simulation of OXPHOS regulation, the model was not able
to predict the data obtained in vivo for the beating heart, oxidative
skeletal muscle and in hepatocytes stimulated by different hormones
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additional mechanism causing a stimulation of mitochondria by
extramitochondrial Ca2+ which acts together with the Ca2+ activation
of the work load (parallel activation) [9,60–62]. However, up to now
there was no known biochemical mechanism responsible for that.
Interestingly, the effect of RR on cardiac contractility may be even
beneﬁcial, so that RR has been viewed as a cardioprotective drug [54].
The in vivo results obtained in the presence of RR do not accordwith the
understanding that Ca2+ ions, after penetrating mitochondrial inner
membranes, activate dehydrogenases and thereby exert positive
inotropic effects. Obviously, the RR has much less effect on OXPHOS in
perfused tissues [50–54] than in isolated mitochondria [23,49]. Such
modest RR effects in vivo point to a possibility of additionalmechanisms
of Ca2+-dependent regulation that can operate in vivo but not in vitro,
this difference probably stemming from the substrate-speciﬁc and
location-speciﬁc nature of the regulatory effects of Ca2+ (see below). On
the other hand, it is possible that ATP formation may be largely
preserved in RR-treated hearts by the stimulation of OXPHOS through
other intrinsic mechanisms, e.g. through an increase in ADP concentra-
tion, which also strongly stimulates the α-KGDH [22,25,26].
Summarising, we can state that there are signiﬁcant experimental
ﬁndings in vivowhich are not in linewith a hypothesis of the exclusive
regulation of OXPHOS by intramitochondrial Ca2+ effects on dehy-
drogenases. It seems that the importance of these effects has been
overestimated in the past. Therefore, an alternative mechanism of
OXPHOS regulation by extramitochondrial Ca2+ should be considered,
as described below (Fig. 1).
3. OXPHOS regulation by extramitochondrial Ca2+
3.1. Stimulation of glutamate-dependent respiration by
extramitochondrial Ca2+
We have recently shown that glutamate-dependent respiration in
isolated brain mitochondria is reversibly activated by extramitochon-
drial Ca2+ [63,64]. This unexpected discovery was made by using an
incubation medium containing 100 µM EGTA, which keeps Cafree2+
negligibly low (150 nM Cafree2+ ). As shown in Fig. 2A we used the
multiple substrate inhibitor protocol that was especially designed for
quantiﬁcation of mitochondrial defects in complex-I-related metab-
olism [65].With 10 mMglutamate and 2 mMmalate as substrates, the
addition of 2.5 mM ADP induced an unusually low glutamate-
dependent respiration rate (state 3glu/mal). To clarify whether such a
modest respiration rate resulted from an insufﬁcient complex-I-
related metabolism, we measured the complex-II-dependent respi-Fig. 2. Exclusive activation of glutamate-dependent state 3 respiration of brain mitochondr
mitochondria obtained by high-resolution respirometry at various concentrations of extramito
incubated with 10 mM glutamate+2 mMmalate as substrates (Cafree2+ =150 nM, adjusted by
the phosphorylation-related respiration (state 3); R, 1.5 µM rotenone to inhibit the respiratory
carboxyatractyloside to block adenine nucleotide carrier; D, a fewmg dithionite. Blue lines indi
the rate of respiration (right ordinate). The height of peaks correlates with the rate of respiratio
in A butwith addition of Ca2+ throughout themeasurement (Cafree2+ =4.9 µM) and omission of c
in D butwith 10 mM succinate+1.5 µM rotenone as substrates. F, Ca2+ titration of glutamate-d
ADP) and state 4 (without ADP) without (◯) and with ( ) 250 nM RR. Extramitochondrial Cration by adding the speciﬁc complex I inhibitor rotenone and
succinate as a complex-II-speciﬁc substrate (state 3suc respiration).
State 3glu/mal respiration was corresponded to only 69% of state 3suc
respiration. However, if the same experiment was performed in the
presence of 1.35 µM Cafree2+ (Fig. 2B), state 3glu/mal respiration was
110% of that of state 3suc (Fig. 2A,B). Thus, the increase in Cafree2+
induced a normalisation of the mitochondrial complex-I-dependent
respiration in normal brain mitochondria. Ca2+ activation was not
limited to the mitochondrial capacity of OXPHOS, but rather to its
efﬁcacy in metabolising glutamate, as succinate strongly enhanced
respiration above state 3glu/mal. With pyruvate/malate (Fig. 2D), state
3 respiration signiﬁcantly exceeded that of state 3glu/mal (Fig. 2D).
However, Ca2+ addition did not augment state 3pyr/mal respiration
(Fig. 2D). Fig. 2E demonstrates that there was also no Ca2+ effect on
complex-II-dependent state 3 with succinate/rotenone.
In a second approach, state 3 respiration of brainmitochondriawas
titrated by sequential Ca2+ additions (Fig. 2F). Again, state 3glu/mal
respiration was very low under conditions of low Cafree2+ , but increased
stepwise until Cafree2+ reached 2 µM. Kinetic analyses of Ca2+ activation
revealed a half-activation constant S0.5 of 0.3 µM Cafree2+ [63,64].
Further Ca2+ additions gave rise to an inhibitory effect. Than the
same Ca2+ titration was performed but in the additional presence of
250 nM RR. All the data points of state 3 respiration at a Ca2+
concentration below 2 µM were identical, irrespective of whether
they were measured in the presence or the absence of RR. Differences
only occurred at Ca2+ concentrations above 2 µM, indicating that at
lower Ca2+ concentrations under our experimental conditions no Ca2+
can be accumulated by the mitochondria since the KM for this process
is N3 µM [Gellerich et al., unpublished]. At higher Ca2+ additions
respiration becomes increasingly inhibited owing to rising Ca2+
overload, while RR prevents this as expected. Ca2+ titration with and
without RR was also performed under state 4 conditions. A very small
but signiﬁcant increasing of respiration was observed at 1 µM Cafree2+ .
At higher Ca2+ concentrations a further increase of respiration was
observed only in the absence of RR followed by an inhibition due to
Ca2+ overload.
When one compares the metabolic pathways for oxidation of the
three substrates glutamate, pyruvate and succinate, it becomes
evident that it is not the respiratory chain including F0F1ATPase, but
rather the substrate supply metabolism with glutamate which should
contain the reaction which is exclusively sensitive to changes of
extramitochondrial Ca2+ under these conditions. A literature search
for proteins with an external regulatory Ca2+ binding site and, thus,
the ability to mediate the extramitochondrial actions of Ca2+ pointed
to aralar as a potential candidate (Fig. 1).ia by extramitochondrial Ca2+ in the nanomolar range. A–E, Respirograms of rat-brain
chondrial Cafree2+ as indicated by horizontal arrows. A, Isolated rat-brain mitochondria were
0.1 mM EGTA). Additions: M, 0.06 mg/ml brain mitochondria; A, 2.5 mM ADP to activate
chain complex I; S, 10 mM succinate as substrate of respiratory chain complex II; C, 5 µM
cate the oxygen concentration in the oxygraph (left ordinate), whereas red lines represent
n (nmol O2/mgmitochondrial protein). B, as in A but with increased Cafree2+ =4.9 µM. C, as
omplex I inhibition. D, as in C butwith 10 mMpyruvate+2 mMmalate as substrates. E, as
ependent respiration of brainmitochondria under conditions of state 3 (adjusted by 2 mM
a2+ was increased stepwise as indicated.
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extramitochondrial Ca2+
Glutamate is taken up by mitochondria either via aralar, leading to
its subsequent transamination by aspartate amino transferase (inhi-
bitable by aminooxyacetate AOA, [66,67] and ribulose-5-phosphate
[68]), or via the glutamate/OH carrier, followed by its deamination by
glutamate dehydrogenase [67,69]. However, the activity of the
glutamate/OH carrier is low in most tissues, except liver and kidney
[69]. Aralar has regulatory Ca2+-binding sites on its long, hydrophilic
amino-terminal extension harbouring EF-hand motifs that face the
IMS [68,72,76]. There are two mammalian isoenzymes of the AGC,
aralar (occurring in brain and skeletal muscle) and citrin (occurring in
liver), while in the heart both isoenzymes are present [68]. As shown
by the extensive work of Satrustegui [68,70–75] and Palmieri [76],
aralar – as a central enzyme of the malate–aspartate shuttle (MAS) –
transports reducing hydrogen equivalents (of cytosolic NADH) into
the mitochondria, this reaction being strongly regulated by extra-
mitochondrial Ca2+ with an S05 of 300 nM Cafree2+ [68,72]; the latter
value is in line with the S0,5=260 nM measured for the extramito-
chondrial Ca2+ activation of glutamate-dependent respiration of brain
mitochondria [63,64]. It is therefore very likely that activation of state
3glu/mal respiration by extramitochondrial Cafree2+ is mediated by
enhanced transport of glutamate into the mitochondrial matrix by
aralar [63,64,71,72,76]. Since the NADH concentration in the matrix is
larger than in the cytosol this transport requires energy which is
supplied from the membrane potential (ΔΨ). The electrogenic nature
of the aralar reaction is realizedby cotransport of protons in addition to
glutamate making this carrier unidirectional [77–79]. The afﬁnity for
glutamate (KM=0.2 mM) is lower than for aspartate (KM=0.5 mM)
and these values do not change with the membrane potential. The
transport rate constant increases with membrane potential but does
not change the substrate afﬁnities [77–79].
The great importance of the MAS for the supply of substrate to
mitochondria is supported by the ﬁnding that inhibition of MAS
attenuates the respiration of isolated synaptosomes [80] and
suppresses the contractile function of the perfused, working heart
[81] when glucose or lactate is oxidised. On the other hand, full
contractile functionality can be observed if pyruvate is used in the
presence of AOA [81]. Satrustegui discovered the stimulation of the
MAS by cytosolic Ca2+ [68,71–75], but did not take account of the
importance of aralar for the regulation of OXPHOS.
3.3. ATP-Mg/Pi carrier
The ATP-Mg/Pi carrier was the ﬁrst known mitochondrial carrier
with an absolute requirement for extramitochondrial Ca2+ due to the
existence of a EF-hand Ca2+ binding motif [68,82]. It transports ATP-
Mg in exchange for phosphate and is responsible for the net of
adenine nucleotides into or out of the mitochondria. In this way the
Ca2+-dependent carrier can change the mitochondrial adenine
nucleotide content. Interestingly, there are also calcium-independent
mitochondrial ATP-Mg/Pi carriers [83]. Activity of the carrier depends
on pH gradient and is suppressed by uncouplers [84]. The fact that the
electroneutral net adenine nucleotide transport is not affected by RR
demonstrates its strict dependence on extramitochondrial Ca2+ [85].
In rat-liver mitochondria, increasing Ca2+ from 1 to 4 µM causes a
decrease in KM but does not change the Vmax of the carrier [85]. In
yeast the S0.5 is even larger (15 µM Ca2+) [86]. Yeast mitochondria can
import cytosolic ATP via the ATP-Mg/Pi carrier for generation of
mitochondrial membrane potential [86]. In mammalian cells, such a
mechanism could be important under hypoxic conditions [87]. The
ATP-Mg/Pi carrier increases the mitochondrial adenine nucleotides in
post-natal development [86,87] allowing higher rates of OXPHOS [88–
90] because elevated ATP- and ADP-contents can down-modulate the
control of the AdN translocator over the OXPHOS [90]. Since this is along-term process, it remains to be seen whether short-term changes
in the concentrations of mitochondrial adenine nucleotides can occur.
In summary, owing to the relative insensitivity of the ATP-Mg/Pi
carrier to Ca2+ it is not probable that this carrier is involved in the
short-term adaptation of mitochondria to an increased work load.
3.4. FAD-glycerol-3-phosphate dehydrogenase
The mitochondrial FAD-dependent glycerol-3-phosphate dehy-
drogenase (FAD-GPDH), together with cytoplasmic NAD-linked
GPDH, acts as the glycerol-3-phosphate shuttle (GPS) that transports
reducing hydrogen equivalents (of NADH) into the mitochondria [91–
93]. Since this enzyme reduces ubiquinone without the participation
of mitochondrial complex I, the GPS has a reduced energy yield of the
transported hydrogen in comparison with the MAS. It has been found
that FAD-GPDH is located in the outer site of the mitochondrial inner
membrane [94] and is accessible for cytosolic Ca2+ [95]. An increased
activity of this pathway induced through elevated FAD-GPDH activity
was thought to be one possible energy-dissipating mechanism [96].
FAD-GPDH from several mammalian tissues is stimulated by Ca2+
[91–93,95–102]. The KM of FAD-GPDH is high (4–9 mM) but
activation by Ca2 results in a decrease in the KM for GP (1 mM),
whereas the Vmax is not changed [91–93,97]. RR does not affect the
stimulation by Ca2+ of ﬂight-muscle mitochondria, indicating that the
Ca2+-binding site is located on the outer side of the mitochondrial
inner membrane [97]. The mammalian FAD-GPH contains EF-hand
motifs at the carboxy terminus of the enzyme which are responsible
for the activation by Ca2+ [95]. In mitochondria of pancreatic ß-cells,
GP-dependent respiration is strongly activated by Ca2+, with an S0.5
between 80 [99] and 300 nM [98]. It has been assumed that the
physiological role of the GPS is to keep the cytosolic pyridine
nucleotides in the oxidised state, thereby making them effective in
sustaining the oxidation of glucose [99]. The activity of FAD-GPDH is
increased by T3-induced hyperthyreosis in the heart, liver and kidney,
but not in the brain [100]. Brain mitochondria possess a considerable
activity of FAD-GPDH, responsible for a Ca2+-dependent activation of
ROS formation by reverse electron transport [101]. Since the main
substrate of brain cells is glucose, there should be sufﬁcient glycolytic
intermediates for transport of reducing hydrogen via the GPS
into brain mitochondria. Therefore, this shuttle may contribute to
the Ca2+-dependent substrate supply to brain mitochondria.
3.5. Porin pore (VDAC)
Recent results indicate that the porin pore is an important regulator
ofmitochondrial function [103–105]. Allmitochondrialmetabolites, e.g.
ADP, ATP, Cr, CrP and Ca2+ enter themitochondria by diffusing through
the porin pores of outer membranes along their diffusion gradients.
There exist evidences that rate-dependent concentration gradients up
to 15 µM between the IMS and the cytosol can be formed for adenine
nucleotides [11–15,106–109]. These gradients cause compartmentation
if the metabolite concentrations are sufﬁciently small, as is the case for
ADP and Ca2+ but under normal circumstances not for ATP, Cr or CrP
[11,12]. Most data on the permeability of the porin pore have been
obtained with isolated mitochondria under isotonic conditions. How-
ever, simulating the cellular oncotic pressurewith dextrans or albumins
resulted in severalfold increased KM for ADP in regulation of OXPHOS in
heart mitochondria [11–15]. Furthermore, the conductivity of the pores
inserted into lipid membranes decreases in the presence of added
macromolecules [109,110]. It has been shown that also NADH favours
closed states of the pore [111]. Very recent data indicate that interaction
of porin with the cytoskeletal protein tubulin further increases the
diffusion resistance for movement of adenine nucleotides through the
pore [112,113]. Likewise, other cytoskeletal proteins – actin [114], and
hexokinase-1 [115,116] – interact with porin, decreasing their pene-
trability. Because tubulinﬁlaments linkmitochondria to sarcomeres and
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act as a complex spatial system; hence, muscle contraction should
markedly modulate the dynamic compartmentation of ADP [117]. The
correctness of this assumption has been recently demonstrated by a
series of different experiments [17,19]. In one set of studies, it was
shown that endogenous ADP released from the ATPase reaction cannot
be fully equilibrated with the ADP pool in the medium surrounding the
skinned cardiomyocytes [17,19,118]. Moreover, a powerful ADP-
trapping system consisting of pyruvate kinase and phosphoenolpyr-
uvate was also unable to capture ADP formed by ATPases and
stimulating OXPHOS [19,118,119]. On the other hand, it was found
that endogenous ADP was muchmore effective in stimulating OXPHOS
than was ADP added to skinned cells [17,19]. Altogether, these results
led to conclusion that mitochondria and ATPases indeed form the
complexes which at least are partially separated from the cytosol
[19,118,119]. Another interesting ﬁnding was that strong contractions
of skinned cardiomyocytes induced by micromolar concentrations of
Ca2+ resulted in an increased afﬁnity for ADP of mitochondria within
these complexes, revealed as a decreasedKM for ADP in the regulation of
respiration [119]. It thus appears that owing to mechanical interactions
of mitochondria and sarcomeres, probably mediated by cytoskeletal
proteins, the forces transmitted from the latter can dynamically
modulate the porin pore's permeability for ADP [119]. In addition to
the mechanisms described, the permeability of porin pores for anions
and cations can be modulated by the electrical potential [103–105].
Because the porin protein possesses a Ca2+-binding site it is expected
that Ca2+ ions can also control the status of porin pores [120,121].
Evidences for this assumption have been increased very recently by
experiments showing that nanomolar Ca2+ concentrations are sufﬁ-
cient to increase the permeability of the MOM towards ADP [122].
3.6. F0F1ATPase
First suggestions that mitochondrial F0F1ATPase may be regulated
directly by matrix Ca2+ came from the studies of Harris and Das
[123,124]. It is assumed that increasing Ca2+ could activate the
F0F1ATPase, but the mechanism has remained unclear because Ca2+
does not activate isolated F0F1ATPase [20,126]. It has been suggested
that the activity of F0F1ATPase is controlled by an inhibitor protein IF1
which inhibits the F1ATPase at a molar ratio of 1:1 [126–130] and by a
calcium-binding inhibitor protein that is considered to confer Ca2+-
dependence upon the F0F1ATPase [131,132]. Balaban assumes that
extramitochondrial Ca2+, in combination with other proteins, regulates
a post-translational process changing the F0F1ATPase activity [20,125].
However, the mechanism of this activation remains to be resolved [20].
In a series of studies Territo demonstrated that Ca2+ is able to rapidly
increase the velocity of ATP production by the F0F1 ATPase at a given
driving force [20,133–136]. Since all these experiments [133–136] were
performed with isolated mitochondria and glutamate/malate as
substrates, the conclusions concerning the F0F1ATPase may be ques-
tioned, especially in view of the fact that these authors did not take into
account the possibility that extramitochondrial Ca2+ could activate the
glutamate entry into the mitochondria which then could cause an
activation of OXPHOS by increasing substrate supply [63,64] (see
above). Since the extramitochondrial Ca2+ activation of isolated heart
mitochondria only occurs in the presence of glutamate – but not of
pyruvate or succinate– as a substrate [63,64] it seems that the activation
observed by Territo et al. is not caused by activation of F0F1ATPase but is
a consequence of the mitochondrial uptake of glutamate via aralar in
dependence on the concentration of extramitochondrial Ca2+[63,64].
3.7. Cytochrome-c-oxidase
Kadenbach demonstrated a cAMP-dependent tyrosine phosphory-
lation site in liver cytochrome-c-oxidase (COX) subunit I. Its phos-
phorylation decreases both Vmax and its afﬁnity for cytochrome c[137,138]. Large concentrations of Ca2+ (N100 µM) are required to
dephosphorylate COX in intact mitochondria [137,138], indicating that
this activation may occur under extreme conditions but cannot
contribute to the regulation at normal Ca2+ levels [20].
3.8. Permeability transition pore
TheCa2+-linkedopeningof thepermeability transitionpore involved
in many physiological and pathopysiological processes is described in
numerous reviews [eg. 139–141]. Increasing intramitochondrial Ca2+
opens the PTP by activating the mitochondrial cyclophilin D [139–143].
In this process Ca2+may have several roles. Increased Ca2+ alone and its
uptake into mitochondria may cause PT. Further, other stressors may
decrease the threshold for Ca2+ causing PT even at unchanged Ca2+ but
at increased other stressors [140]. Bernardi proposed a model were PTP
has besides the internal also an external Me2+ binding site that can
decrease the pore open probability [141,142]. This binding site interacts
with extramitochondrial Mg2+ and Ca2+ [141,142]. Via this mechanism
cytosolic Ca2+ may act as an inhibitor of PT [141–143].
4. Impaired extramitochondrial Ca2+ regulation at transgenic
HD models
Huntington's disease (HD) is a progressive neurodegenerative
disorder caused by a CAG repeat expansion in the coding region of the
huntingtin (htt) gene resulting in an expandedpolyglutamine stretch in
the htt protein (httexpQ) [144,145]. The CAG repeat length of httexpQ
correlates inversely with the time point of disease onset [146].
Unmodiﬁed htt, and even httexpQ in HD, are expressed abundantly in
most tissues [145], but neither the biological function of htt nor the
mechanism of cytotoxic action of httexpQ has been understood [147].
Several lines of evidence suggest that the cell's energy metabolism is
impaired in HD [for reviews see 148,149], possibly due to mitochon-
driotoxic effects of httexpQ [147–154]. Indeed, decreased Ca2+ accumu-
lation capacities of mitochondria from brain of YAC72Qmice [150], from
skeletal muscle of htt140Q R6/2 mice [151], from liver of htt111Q mice
[152], from HD patient's lymphocytes [150], or ﬁbroblasts [157] and
from htt111Q striatal progenitor cells [153] have been reported.
Furthermore, impaired mitochondrial function and Ca2+ dyshomeos-
tasiswere detected in PC12 cells after transfectionwith httexpQ plasmids
[154]. In contrast, increased Ca2+-loading capacities were observed in
brain mitochondria from several HD mice lines [155,156].
Recently we investigated skeletal muscle mitochondria from 15-
week-old R6/2 mice respirometrically [150] by means of the multiple
substrate inhibitor titration protocol [65]. At a Ca2+ concentration of
0.9 µM, the respirometric properties of HD and WT mitochondria
were identical (Fig. 3A,C). In both cases the rates of complex-I-
dependent respiration were higher (165%) than those of complex-II-
dependent respiration. If, however, the investigation was performed
in the additional presence of 10 µM (Fig. 3B,D) the complex-I-
dependent respiration was much more inhibited in HD mitochondria
than in the controls [151]. On the contrary, the succinate-dependent
respiration was nearly unaffected in both HD and WT mitochondria
[151]. These data show that httexpQ affects mitochondria not only from
brain but also in skeletal muscle and that the impairment can be
detectable only at elevated Ca2+ concentration.
We therefore developed a protocol for routine investigation of
diseased mitochondria by means of Ca2+ titrations under state 3
conditions. In an investigation of brain and striatal mitochondria
isolated from HD rat, we detected that all rates of state 3 respiration
were lower than the corresponding rates in controls [63]. As shown in
Fig. 4 inhibition of state 3 respiration of HD mitochondria started at
lower Ca2+ concentrations than in the controls (Fig. 4). Moreover, we
also detected lowered membrane potentials, decreased Ca2+ uptake
rates and depressed Ca2+ threshold values [63]. The impairment of
the Ca2+ uptake kinetics was abolished by the addition of Cyclosporin
Fig. 3. Ca2+-induced inhibition of complex-I-dependent respiration in isolated muscle
mitochondria from wild type (WT) and transgenic R6/2 Huntington mice. Multiple
substrate inhibitor titration of respiration ofmitochondria isolated from skeletalmuscle of
WT (Al, B) and HD mice (C, D) at the age of 14 to 16 weeks. Typical protocols of three
independent experiments are shown. Isolatedmitochondria (0.5 mg/ml) were incubated
in medium containing 5 mM MgCl2, 75 mM mannitol, 25 mM sucrose, 100 mM KCl,
10 mMKH2PO4, 0.5 mMEDTA, 20 mMTris, pH7.4 and 10 mMpyruvate plus 2 mMmalate
as substrates. Additions: ADP 2 mMadenosine diphosphate, R, 1.5 µM rotenone; S, 10 mM
succinate; CAT, 10 µM carboxyatractyloside; Ca10 µM2+ , 10 µM Ca2+. In the presence of
0.9 µMCa2+(A,C) respirometric properties ofWTandHDmitochondriawerenotdifferent
fromeachother. State 3complex I respirationwas about 150%of state 3complex II respiration in
both samples but after challenge with 10 µM Ca2+ state 3 these values were 100% in WT
but 20% in HD mitochondria, indicating a much more pronounced instability of HD
mitochondria towards Ca2+ stress. For further details see [151].
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ﬁbroblasts of an HD patient with htt43Q [157].
Irrespective of the underlying mechanism, htt51Q-dependent
changes in mitochondrial regulation may uncover important patho-
physiological consequences. For instance, decreased Ca2+ thresholds
of httexpQ mitochondria for undergoing PT might be responsible for
accelerated mitochondrial cell death, in particular under conditions of
elevated cytosolic Ca2+ concentration. Moreover, we demonstrated
that protective CsA effects occur not only under conditions of Ca2+
overload, but also within physiological concentration ranges of
extramitochondrial Ca2+ in htt51Q mitochondria. This may have
important, disease-speciﬁc consequences in vivo if an altered Ca2+
homeostasis affects the energy metabolism and vice versa.
In summary, our data provide several lines of evidence for htt51Q-
induced pathomechanisms underlying the initiation and progression
of HD. Ca2+-dependent impairments of mitochondrial oxidative
phosphorylation due to a limited substrate supply and/or altered PT
were identiﬁed as a major cause for the increased vulnerability of HD
mitochondria towards Ca2+ stress. We assume that the Ca2+-binding
sites at the mitochondrial surface regulating the substrate supply for
mitochondria can act as targets for mitochondriotoxic proteins
(Fig. 1). Regulatory Ca2+ binding sites at the surface of mitochondria
can be occupied by binding to httexpQ or other neurodegeneratively
acting proteins, causing an impaired Ca2+ regulation of mitochondria
that in turn leads to energetic depression andmitochondrial cell death
[149].Fig. 4. Impaired mitochondrial function in isolated brain mitochondria of HD rats. The
mitochondria were isolated from brains of 24-month-old htt51Q (HD) and 18–27-
month-old wild type (WT) rats. Respirometric investigation of WT (●) and HD ( )
mitochondria (0.06 mg mitochondrial protein/ml) were performed in 100 µM EGTA
medium with 10 mM glutamate plus 2 mM malate as substrates. After addition of
2.5 mM ADP adjusting state 3glu/mal six sequential additions by 20 µM Catotal2+ were done
increasing the Cafree2+ from 150 nM 30 µM. Data are means±S.E. of 15 (WT) 14 (HD)
measurements. Red and black dashed arrows indicate the maximum rates at
corresponding Cafree2+ concentrations. All respiration rates of htt51Q mitochondria were
signiﬁcantly lower than the corresponding rates of WT mitochondria (Pb0.01). For
further details see [63].5. Conclusions
Since the time when in vivo 31P-NMR spectroscopy was ﬁrst
applied to investigate energy metabolism in intact tissues, it has
become evident that the original idea of output activation of OXPHOS
by ADP could not explain the homeostasis of phosphorylation
potentials at increasing work load. In attempts to solve this problemand to explain metabolic stability, two hypotheses have been
proposed.
One of them considers thatmitochondria and ATPases are linked to
each other by specialised systems of energy transfer mediated by CK
and AK isoenzymes, which ensure effective transfer of energy-rich
phosphate groups frommitochondria to ATPases, in exact response to
altered work load, but without ﬂuctuations of adenine nucleotides in
the cytoplasm.
The other hypotheses consider that ATPases and OXPHOS are
regulated simultaneously by Ca2+ ion concentrations. This hypothesis
is largely based on the studies of McCormack, Denton and Hansford,
who demonstrated in more than 30 papers that PDHC, α-KGDH
and ICDH can be regulated by matrix Ca2+ after its accumulation via
the Ca2+-uniporter. With the development of optical Ca2+ sensors it
became clear beyond reasonable doubt that matrix Ca2+ concentra-
tions change in parallel with cytosolic alterations of Ca2+. This
evidence was taken as proof of the mechanism whereby cytosolic
Ca2+ is taken up by the mitochondria for the regulation of matrix
dehydrogenases. In view of current evidence, the intramitochondrial
Ca2+ activation theory is limited because it ignores the evidence that
mitochondrial processes can also be activated by Ca2+ ions indepen-
dently of their accumulation in the matrix. Indeed, there exist at least
three mitochondrial processes that can be regulated by extramito-
chondrial Ca2+ ions. Besides the MgATP/Pi carrier there are two
enzymes involved in shuttle mechanisms for transporting cytosolic
reducing hydrogen (NADH) into the mitochondria: aralar/citrin and
FAD-GPDH. The fact that the GPS is activated by extramitochondrial
Ca2+was discovered 40 years ago. For several years it has been known
that MAS activity is also regulated by Cacyt2+, owing to the action of
aralar. Now,wehave observed that glutamate-dependentOXPHOS can
be also up-regulated through the activation of aralar by extramito-
chondrial Ca2+ (S0.5=0.3 µMCa2+). This activation – occurring also in
the presence of saturating glutamate concentrations – increases the
Vmax of glutamate-dependent OXPHOS (+300%). In contrast, Ca2+
does not increase the Vmax but rather decreases the KM of PDH, ICDH,
KGDH and FAD-GPDH.
Moreover, interactions with cytosolic Ca2+ have been described
for the PTP, the Ca2+ uniporter and for the porin pores and, in less
thoroughly explored state, for the F0F1ATPase and the cytochrome c
oxidase.
The existence of regulatory Ca2+-binding sites at the surface of
mitochondria is important for the glucose-based substrate supply,
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deﬁnitely does not use fatty acids or ketone bodies (under normal
conditions). Therefore the activity of both shuttles, the MAS and GPS
controlled by extramitochondrial Ca2+, can change the hydrogen
supply of brain mitochondria. Moreover, aralar can actively pump
glutamate, a principal substrate, into brain mitochondria as fuel for
Ca2+-dependent dehydrogenases.
Interactions of mitochondriotoxic proteins such as httexpQ with
these regulatory Ca2+-binding sites can play a role in the pathophys-
iology of neurodegenerative diseases by induction of energetic
depression and cell death.
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